Study greatly underestimates the cost effectiveness of statin treatment

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7065.1142a (Published 02 November 1996) Cite this as: BMJ 1996;313:1142
  1. J J V McMurray,
  2. C E Morrison
  1. Consultant cardiologist Consultant in public health medicine University of Glasgow, Glasgow G12 8QQ

    EDITOR,—The analysis of P D P Pharoah and W Hollingworth of the cost effectiveness of lowering cholesterol concentration is flawed.1

    With respect to secondary prevention, the authors do not take account of the significant reductions in the incidence of strokes and transient ischaemic attacks, chronic heart failure, and unstable angina requiring admission with simvastatin in the Scandinavian simvastatin survival study.2 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial